FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138563553> ?p ?o ?g. }

• W2138563553 endingPage "4389" @default.
• W2138563553 startingPage "4382" @default.
• W2138563553 abstract "Surveillance studies conducted in the United States over the last decade have revealed increasing resistance among community-acquired respiratory pathogens, especially Streptococcus pneumoniae, that may limit future options for empirical therapy. The objective of this study was to assess the scope and magnitude of the problem at the national and regional levels during the 2005-2006 respiratory season (the season when community-acquired respiratory pathogens are prevalent) in the United States. Also, since faropenem is an oral penem being developed for the treatment of community-acquired respiratory tract infections, another study objective was to provide baseline data to benchmark changes in the susceptibility of U.S. respiratory pathogens to the drug in the future. The in vitro activities of faropenem and other agents were determined against 1,543 S. pneumoniae isolates, 978 Haemophilus influenzae isolates, and 489 Moraxella catarrhalis isolates collected from 104 U.S. laboratories across six geographic regions during the 2005-2006 respiratory season. Among S. pneumoniae isolates, the rates of resistance to penicillin, amoxicillin-clavulanate, and cefdinir were 16, 6.4, and 19.2%, respectively. The least effective agents were trimethoprim-sulfamethoxazole (SXT) and azithromycin, with resistance rates of 23.5 and 34%, respectively. Penicillin resistance rates for S. pneumoniae varied by region (from 8.7 to 22.5%), as did multidrug resistance rates for S. pneumoniae (from 8.8 to 24.9%). Resistance to beta-lactams, azithromycin, and SXT was higher among S. pneumoniae isolates from children than those from adults. beta-Lactamase production rates among H. influenzae and M. catarrhalis isolates were 27.4 and 91.6%, respectively. Faropenem MICs at which 90% of isolates are inhibited were 0.5 mug/ml for S. pneumoniae, 1 mug/ml for H. influenzae, and 0.5 mug/ml for M. catarrhalis, suggesting that faropenem shows promise as a treatment option for respiratory infections caused by contemporary resistant phenotypes." @default.
• W2138563553 created "2016-06-24" @default.
• W2138563553 creator A5001771999 @default.
• W2138563553 creator A5019407143 @default.
• W2138563553 creator A5063814702 @default.
• W2138563553 creator A5066245688 @default.
• W2138563553 creator A5087463586 @default.
• W2138563553 date "2007-12-01" @default.
• W2138563553 modified "2023-10-16" @default.
• W2138563553 title "National and Regional Assessment of Antimicrobial Resistance among Community-Acquired Respiratory Tract Pathogens Identified in a 2005-2006 U.S. Faropenem Surveillance Study" @default.
• W2138563553 cites W1973938449 @default.
• W2138563553 cites W1976049790 @default.
• W2138563553 cites W2014171071 @default.
• W2138563553 cites W2018379773 @default.
• W2138563553 cites W2019822176 @default.
• W2138563553 cites W2024204011 @default.
• W2138563553 cites W2047873931 @default.
• W2138563553 cites W2057987928 @default.
• W2138563553 cites W2079382261 @default.
• W2138563553 cites W2079712827 @default.
• W2138563553 cites W2087431853 @default.
• W2138563553 cites W2094212902 @default.
• W2138563553 cites W2096228389 @default.
• W2138563553 cites W2097667778 @default.
• W2138563553 cites W2100498945 @default.
• W2138563553 cites W2115071132 @default.
• W2138563553 cites W2119135361 @default.
• W2138563553 cites W2128396188 @default.
• W2138563553 cites W2137532164 @default.
• W2138563553 cites W2150211512 @default.
• W2138563553 cites W2159004468 @default.
• W2138563553 cites W2169725634 @default.
• W2138563553 cites W325864058 @default.
• W2138563553 cites W4229933659 @default.
• W2138563553 doi "https://doi.org/10.1128/aac.00971-07" @default.
• W2138563553 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2168020" @default.
• W2138563553 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17908940" @default.
• W2138563553 hasPublicationYear "2007" @default.
• W2138563553 type Work @default.
• W2138563553 sameAs 2138563553 @default.
• W2138563553 citedByCount "62" @default.
• W2138563553 countsByYear W21385635532012 @default.
• W2138563553 countsByYear W21385635532013 @default.
• W2138563553 countsByYear W21385635532014 @default.
• W2138563553 countsByYear W21385635532015 @default.
• W2138563553 countsByYear W21385635532018 @default.
• W2138563553 countsByYear W21385635532019 @default.
• W2138563553 countsByYear W21385635532020 @default.
• W2138563553 countsByYear W21385635532022 @default.
• W2138563553 crossrefType "journal-article" @default.
• W2138563553 hasAuthorship W2138563553A5001771999 @default.
• W2138563553 hasAuthorship W2138563553A5019407143 @default.
• W2138563553 hasAuthorship W2138563553A5063814702 @default.
• W2138563553 hasAuthorship W2138563553A5066245688 @default.
• W2138563553 hasAuthorship W2138563553A5087463586 @default.
• W2138563553 hasBestOaLocation W21385635531 @default.
• W2138563553 hasConcept C105702510 @default.
• W2138563553 hasConcept C114851261 @default.
• W2138563553 hasConcept C174802600 @default.
• W2138563553 hasConcept C2776012195 @default.
• W2138563553 hasConcept C2776551000 @default.
• W2138563553 hasConcept C2776925733 @default.
• W2138563553 hasConcept C2778907293 @default.
• W2138563553 hasConcept C2779425571 @default.
• W2138563553 hasConcept C2779708577 @default.
• W2138563553 hasConcept C2780728791 @default.
• W2138563553 hasConcept C2781253189 @default.
• W2138563553 hasConcept C501593827 @default.
• W2138563553 hasConcept C534529494 @default.
• W2138563553 hasConcept C86803240 @default.
• W2138563553 hasConcept C89423630 @default.
• W2138563553 hasConcept C94665300 @default.
• W2138563553 hasConceptScore W2138563553C105702510 @default.
• W2138563553 hasConceptScore W2138563553C114851261 @default.
• W2138563553 hasConceptScore W2138563553C174802600 @default.
• W2138563553 hasConceptScore W2138563553C2776012195 @default.
• W2138563553 hasConceptScore W2138563553C2776551000 @default.
• W2138563553 hasConceptScore W2138563553C2776925733 @default.
• W2138563553 hasConceptScore W2138563553C2778907293 @default.
• W2138563553 hasConceptScore W2138563553C2779425571 @default.
• W2138563553 hasConceptScore W2138563553C2779708577 @default.
• W2138563553 hasConceptScore W2138563553C2780728791 @default.
• W2138563553 hasConceptScore W2138563553C2781253189 @default.
• W2138563553 hasConceptScore W2138563553C501593827 @default.
• W2138563553 hasConceptScore W2138563553C534529494 @default.
• W2138563553 hasConceptScore W2138563553C86803240 @default.
• W2138563553 hasConceptScore W2138563553C89423630 @default.
• W2138563553 hasConceptScore W2138563553C94665300 @default.
• W2138563553 hasIssue "12" @default.
• W2138563553 hasLocation W21385635531 @default.
• W2138563553 hasLocation W21385635532 @default.
• W2138563553 hasLocation W21385635533 @default.
• W2138563553 hasLocation W21385635534 @default.
• W2138563553 hasOpenAccess W2138563553 @default.
• W2138563553 hasPrimaryLocation W21385635531 @default.
• W2138563553 hasRelatedWork W172578268 @default.
• W2138563553 hasRelatedWork W1970045021 @default.
• W2138563553 hasRelatedWork W2017678966 @default.

• next